Insider · CIK 0001399318
Scott R Burell
Files at MBOT (Microbot Medical Inc.), XPON (Expion360 Inc.). First filing -, latest -.
In brief
Scott R Burell files SEC Form 4 as director at MBOT (Microbot Medical Inc.), and also at XPON (Expion360 Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Scott R Burell has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | XPON Expion360 Inc. | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 8,333 | Aug 25, 2026 |
| Apr 1, 2026 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Apr 3, 2026 |
| Oct 16, 2025 | XPON Expion360 Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 40,000 | Oct 21, 2025 |
| Jan 28, 2025 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jan 30, 2025 |
| Nov 2, 2023 | MBOT Microbot Medical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +74,218 | $0.00 | $0 | 74,218 | Nov 6, 2023 |
Questions about Scott R Burell
Answered from the filings on this page, as of the latest one.
Is Scott R Burell buying or selling?
Scott R Burell has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Scott R Burell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott R Burell has 0.
Where does Scott R Burell file Form 4?
Scott R Burell has filed Form 4 at MBOT (Microbot Medical Inc.); XPON (Expion360 Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.